A new PPARα/γ co-agonist for the treatment of dyslipidemia

被引：0
|
作者：
Clay, C [1 ]
Tigon, X [1 ]
Ding, S [1 ]
Braileanu, G [1 ]
Hansen, B [1 ]
机构：
[1] Univ Maryland, Baltimore, MD 21201 USA
来源：
ATHEROSCLEROSIS SUPPLEMENTS | 2004年 / 5卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：25 / 25
页数：1
相关论文
共 50 条
  • [41] LY510929:: A highly potent, Non-TZD PPARα,γ dual agonist for the treatment of type 2 diabetes and associated Dyslipidemia
    Etgen, G
    Broderick, C
    Oldham, B
    Bean, J
    Bensch, W
    Montrose, C
    Barr, R
    Zink, R
    Jett, D
    Sha, L
    Ogilvie, K
    Ardecky, R
    Brooks, D
    Rito, C
    Xu, YP
    McCarthy, J
    Kauffman, R
    DIABETES, 2003, 52 : A141 - A141
  • [42] Pharmacological stimulation of NMDA receptors via co-agonist site suppresses fMRI response to phencyclidine in the rat
    Gozzi, Alessandro
    Herdon, Hugh
    Schwarz, Adam
    Bertani, Simone
    Crestan, Valerio
    Turrini, Giuliano
    Bifone, Angelo
    PSYCHOPHARMACOLOGY, 2008, 201 (02) : 273 - 284
  • [43] New Trends in Dyslipidemia Treatment
    Jang, Albert Youngwoo
    Lim, Soo
    Jo, Sang-Ho
    Han, Seung Hwan
    Koh, Kwang Kon
    CIRCULATION JOURNAL, 2021, 85 (06) : 759 - 768
  • [44] Discovery of a Potent Nicotinic Acid Receptor Agonist for the Treatment of Dyslipidemia
    Qin, Jun
    Rao, Ashwin
    Chen, Xiao
    Zhu, Xiaohong
    Liu, Zhidan
    Huang, Xianhai
    Degrado, Sylvia
    Huang, Ying
    Xiao, Dong
    Aslanian, Robert
    Cheewatrakoolpong, Boonlert
    Zhang, Hongtao
    Greenfeder, Scott
    Farley, Constance
    Cook, John
    Kurowski, Stan
    Li, Qiu
    van Heek, Margaret
    Chintala, Madhu
    Wang, Ganfeng
    Hsieh, Yunsheng
    Li, Fangbiao
    Palani, Anandan
    ACS MEDICINAL CHEMISTRY LETTERS, 2011, 2 (02): : 171 - 176
  • [45] A new approach to the treatment of dyslipidemia
    Kevelaitiene, Sigita
    Slapikas, Rimvydas
    MEDICINA-LITHUANIA, 2008, 44 (05): : 407 - 413
  • [46] New approaches for the treatment of dyslipidemia
    Maria Mostaza, Jose
    Lahoz, Carlos
    MEDICINA CLINICA, 2014, 142 (07): : 306 - 309
  • [47] Pharmacological stimulation of NMDA receptors via co-agonist site suppresses fMRI response to phencyclidine in the rat
    Alessandro Gozzi
    Hugh Herdon
    Adam Schwarz
    Simone Bertani
    Valerio Crestan
    Giuliano Turrini
    Angelo Bifone
    Psychopharmacology, 2008, 201 : 273 - 284
  • [48] Netoglitazone -: Antidiabetic -: PPARα/PPARγ agonist
    Sorbera, LA
    Castañer, J
    del Fresno, M
    Silvestre, J
    DRUGS OF THE FUTURE, 2002, 27 (02) : 132 - 139
  • [49] Efficacy and Safety of K-877, a Potent and Selective PPAR-a Agonist, in Japanese Patients With Dyslipidemia
    Ishibashi, Shun
    Yamashita, Shizuya
    Arai, Hidenori
    Araki, Eiichi
    Yokote, Koutaro
    Kodama, Tatsuhiko
    CIRCULATION, 2013, 128 (22)
  • [50] Preclinical evaluation of a protracted GLP-1/glucagon receptor co-agonist: Translational difficulties and pitfalls
    Simonsen, Lotte
    Lau, Jesper
    Kruse, Thomas
    Guo, Tingqing
    McGuire, Jim
    Jeppesen, Jacob Fuglsbjerg
    Niss, Kristoffer
    Sauerberg, Per
    Raun, Kirsten
    de la Cour, Charlotta Dornonville
    PLOS ONE, 2022, 17 (03):
12345